Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: Evidence of waning intra-seasonal protection

Eurosurveillance

Volumn 18, Issue 5, 2013, Pages

  Pebody, R G ^a   Andrews, N ^a   McMenamin, J ^b   Durnall, H ^c   Ellis, J ^a   Thompson, C I ^a   Robertson, C ^d,e   Cottrell, S ^f   Smyth, B ^g   Zambon, M ^a   Moore, C ^f   Fleming, D M ^c   Watson, J M ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b HEALTH PROTECTION SCOTLAND   (United Kingdom)

^c ROYAL COLLEGE OF GENERAL PRACTITIONERS   (United Kingdom)

^d UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^e INTERNATIONAL PREVENTION RESEARCH INSTITUTE   (France)

^f PUBLIC HEALTH WALES   (United Kingdom)

^g PUBLIC HEALTH AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CASE CONTROL STUDY; CHILD; CONTROLLED STUDY; DISEASE SURVEILLANCE; DRUG EFFICACY; FEMALE; HUMAN; INFLUENZA A (H3N2); INFLUENZA B; INFLUENZA VIRUS A H3N2; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIMARY MEDICAL CARE; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY TRACT DISEASE; SEASONAL INFLUENZA; UNITED KINGDOM;

EID: 84873314743     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.18.05.20389-en     Document Type: Article

References (17)

1. Health Protection Agency (HPA). Surveillance of influenza and other respiratory viruses in the UK: October 2011-April 2012. London: HPA; Jun 2012. Available from:http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317134705939
2. Begum F, Pebody R.G. Seasonal influenza vaccine uptake amongst GP patient groups in England. Winter season 2011/12. London: HPA; Jun 2012. Available from: https://www.google.se/url?sa=t&rct=j&q=&esrc=s&source=web&cd=1&cad=rja&ved=0CCwQFjAA&url=https%3A%2F%2Fwww.wp.dh.gov.uk%2Fimmunisation%2Ffiles%2F2012%2F06%2FFlu-vaccine-uptake-GP-patients-2011.12.pdf&ei=vOYIUY2rCOWC4gT1koCQAg&usg=AFQjCNGxRbUKWGJSLP336crRF98SgBoHKQ
3. Kissling E, Valenciano M, I-MOVE case-control studies team. Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12. Euro Surveill 2012; 17(15):pii=20146. Available from:http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20146
4. Jiménez-Jorge S, de Mateo S, Pozo F, Casas I, García CM, Castilla J, et al. Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012. Euro Surveill 2012; 17(12):pii=20129. Available from:http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=20129
5. Hardelid P, Fleming DM, McMenamin J, Andrews NJ, Robertson C, Sebastianpillai P, et al. Effectiveness of pandemic and seasonal influenza vaccine in preventing pandemic influenza A(H1N1)2009 infection in England and Scotland 2009-2010. Euro Surveill. 16(2):pii=19763. Available from:http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19763
6. Ellis J, Iturriza M, Allen R, Bermingham A, Brown K, Gray J, et al. Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses. Euro Surveill. 14(22):pii=19230. Available from:http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19230
7. Gunson R, Maclean A, Davies E, Bennett S, Miller R, Carman WF. Development of a multiplex real-time RT-PCR that allows universal detection of influenza A viruses and simultaneous typing of influenza A/H1N1/2009 virus. J Virol Methods. 2010;163(2):258-61.
8. Matrosovich M, Matrosovich T, Carr J, Roberts NA, Klenk HD. Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J Virol. 2003;77(15):8418-25.
9. Zambon M. Laboratory Diagnosis of Influenza. In: Nicholson K, Hay A, Webster RG, editors. Textbook of Influenza. Oxford: Blackwell Science; 1998. pp. 291-313.
10. Wilson IA, Cox NJ. Structural basis of immune recognition of influenza virus hemagglutinin. Annu Rev Immunol. 1990;8:737-71.
11. Ferdinands JM, Belongia EA, Nwasike C, Shay DK. Influenza vaccination status is not associated with influenza testing among children: Implications for observational studies of vaccine effectiveness. Vaccine. 2011;29(10):1935-40.
12. Orenstein EW, De Serres G, Haber MJ, Shay DK, Bridges CB, Gargiullo P, et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol. 2007;36(3):623-31.
13. Hardelid P, Fleming DM, Andrews N, Barley M, Durnall H, Mangtani P, et al. Effectiveness of trivalent and pandemic influenza vaccines in England and Wales 2008-2010: results from a cohort study in general practice. Vaccine. 2012;30(7):1371-8.
14. Skowronski DM, Janjua NZ, De Serres G, Winter AL, Dickinson JA, Gardy JL, et al. A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-11 Season. Clin Infect Dis. 2012;55(3):332-42.
15. Matsushita M, Takeuchi S, Kumagai N, Uehara Y, Matsushita C, Arise K, et al. Prevaccination antibody titers can estimate the immune response to influenza vaccine in a rural community-dwelling elderly population. Vaccine 2012;30(6):1101-7.
16. Brydak LB, Machala M, Myśliwska J, Myśliwski A, Trzonkowski P. Immune response to influenza vaccination in an elderly population. J Clin Immunol. 2003;23(3):214-22.
17. Uyeki TM, Zane SB, Bodnar UR, Fielding KL, Buxton JA, Miller JM, et al. Large summertime influenza A outbreak among tourists in Alaska and the Yukon Territory. Clin Infect Dis. 2003;36(9):1095-102.